Alejandro P. Comellas

ORCID: 0000-0003-1521-7520
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory Support and Mechanisms
  • Asthma and respiratory diseases
  • Air Quality and Health Impacts
  • Lung Cancer Diagnosis and Treatment
  • Neonatal Respiratory Health Research
  • Pediatric health and respiratory diseases
  • Inhalation and Respiratory Drug Delivery
  • Pulmonary Hypertension Research and Treatments
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Long-Term Effects of COVID-19
  • Ion Transport and Channel Regulation
  • Respiratory and Cough-Related Research
  • Radiomics and Machine Learning in Medical Imaging
  • Ion channel regulation and function
  • Air Quality Monitoring and Forecasting
  • Climate Change and Health Impacts
  • COVID-19 diagnosis using AI
  • Atomic and Subatomic Physics Research
  • COVID-19 Clinical Research Studies
  • Medical Imaging Techniques and Applications
  • Cystic Fibrosis Research Advances
  • Smoking Behavior and Cessation
  • Thermal Regulation in Medicine
  • Tracheal and airway disorders

University of Iowa
2016-2025

University of Iowa Hospitals and Clinics
2014-2024

Pulmonary and Critical Care Associates
2017-2024

Louisiana Public Health Institute
2024

Cornell University
2024

University of Washington
2024

National Institutes of Health
2024

Weill Cornell Medicine
2024

Children's Hospital of Philadelphia
2024

University of Pennsylvania
2024

Katherine Lowe Elizabeth A. Regan Antonio Anzueto Erin Austin John H. M. Austin and 95 more Terri H. Beaty Panayiotis V. Benos Christopher J. Benway Surya P. Bhatt Eugene R. Bleecker Sandeep Bodduluri Jessica Bon Aladin M. Boriek Adel R. Boueiz Russell P. Bowler Matthew J. Budoff Richard Casaburi Peter J. Castaldi Jean-Paul Charbonnier Michael H. Cho Alejandro P. Comellas Douglas Conrad Corinne Costa Davis Gerard J. Criner Douglas Curran‐Everett Jeffrey L. Curtis Dawn L. DeMeo Alejandro A. Díaz Mark T. Dransfield Jennifer Dy Ashraf Fawzy Margaret Fleming Eric L. Flenaugh Marilyn G. Foreman Spyridon Fortis Hirut Gebrekristos Sarah Schmidt Grant Philippe Greniér Tian Gu Abhya Gupta MeiLan K. Han Nicola A. Hanania Nadia N. Hansel Lystra P. Hayden Craig P. Hersh Brian D. Hobbs Eric A. Hoffman James C. Hogg John E. Hokanson Karin F. Hoth Albert Hsiao Stephen M. Humphries Kathleen Jacobs Francine L. Jacobson Ella A. Kazerooni V. Kim Woo Jin Kim Gregory L. Kinney Harald Koegler Sharon M. Lutz David A. Lynch Neil R. MacIntye Barry J. Make Nathaniel Marchetti Fernando J. Martínez Diego J. Maselli Anne M. Mathews Meredith C. McCormack Merry‐Lynn McDonald Charlene McEvoy Matthew Moll Sarah S. Molye Susan Murray Hrudaya Nath John D. Newell Mariaelena Occhipinti Matteo Paoletti Trisha M. Parekh Massimo Pistolesi Katherine Pratte Nirupama Putcha M.F. Ragland Joseph M. Reinhardt Stephen I. Rennard Richard Rosiello James C. Ross Harry B. Rossiter Ingo Ruczinski Raúl San Jośe Estépar Frank C. Sciurba Jessica C. Sieren Harjinder Singh Xavier Soler Robert M. Steiner Matthew Strand William W. Stringer Ruth Tal‐Singer Byron Thomashow Gonzalo Vegas‐Sánchez‐Ferrero John W. Walsh

Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity and mortality. Present-day diagnostic criteria are largely based solely on spirometric criteria. Accumulating evidence has identified substantial number individuals without COPD who suffer from respiratory symptoms and/or increased There is clear need for an expanded definition that linked to physiologic, structural (computed tomography [CT]) clinical disease. Using data the Genetic Epidemiology study (COPDGene

10.15326/jcopdf.6.5.2019.0149 article EN Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation 2019-01-01

Autosomal recessive diseases, such as cystic fibrosis (CF), require inheritance of 2 mutated genes. However, some studies indicate that CF carriers are at increased risk for conditions associated with CF. These investigations focused on single and included small numbers subjects. Our goal was to determine whether a range CF-related conditions. Using the Truven Health MarketScan Commercial Claims database (2001-2017), we performed population-based retrospective matched-cohort study. We...

10.1073/pnas.1914912117 article EN cc-by Proceedings of the National Academy of Sciences 2019-12-27

Background The long-term effects of SARS-CoV-2 infection on pulmonary structure and function remain incompletely characterized. Purpose To test whether leads to small airways disease in patients with persistent symptoms. Materials Methods In this single-center study at a university teaching hospital, adults confirmed COVID-19 who remained symptomatic more than 30 days following diagnosis were prospectively enrolled from June December 2020 compared healthy participants (controls) March August...

10.1148/radiol.212170 article EN Radiology 2022-03-15

Quantifying functional small airways disease (fSAD) requires additional expiratory computed tomography (CT) scan, limiting clinical applicability. Artificial intelligence (AI) could enable fSAD quantification from chest CT scan at total lung capacity (TLC) alone (fSADTLC). To evaluate an AI model for estimating fSADTLC, compare it with dual-volume parametric response mapping (fSADPRM), and assess its associations repeatability in chronic obstructive pulmonary (COPD). We analyzed 2513...

10.1164/rccm.202409-1847oc article EN American Journal of Respiratory and Critical Care Medicine 2025-03-12

Novel proteomics platforms, such as the aptamer-based SOMAscan platform, can quantify large numbers of proteins efficiently and cost-effectively are rapidly growing in popularity. However, comparisons to conventional immunoassays remain underexplored, leaving investigators unsure when cross-assay appropriate. The correlation results from with relative protein quantification is explored by SOMAscan. For 63 assessed two chronic obstructive pulmonary disease (COPD) cohorts, subpopulations...

10.1002/pmic.201900278 article EN PROTEOMICS 2020-05-09

Given the increased use of iron-containing nanoparticles in a number applications, it is important to understand any effects that can have on environment and human health. Since iron concentrations are extremely low body fluids, there potential may influence ability bacteria scavenge for growth, affect virulence inhibit antimicrobial peptide (AMP) function. In this study, Pseudomonas aeruginosa (PA01) AMPs were exposed oxide nanoparticles, hematite (α-Fe2O3), different sizes ranging from 2...

10.1039/c3en00029j article EN Environmental Science Nano 2014-01-01

Rationale: The relative roles of mucus plugs and emphysema in mechanisms airflow limitation hypoxemia smokers with chronic obstructive pulmonary disease (COPD) are uncertain.Objectives: To relate image-based measures to obstruction oxygenation patients COPD.Methods: We analyzed computed tomographic (CT) lung images function participants the Subpopulations Intermediate Outcome Measures COPD Study. Radiologists scored on CT images, imaging software automatically quantified percentage....

10.1164/rccm.202006-2248oc article EN American Journal of Respiratory and Critical Care Medicine 2020-11-12

Chronic bronchitis (CB) has been related to poor outcomes in Obstructive Pulmonary Disease (COPD). From a clinical standpoint, we have shown that subjects with CB group moderate severe airflow obstruction were younger, more likely be current smokers, male, Caucasian, had worse health quality of life, dyspnea, and increased exacerbation history compared those without CB. We sought further refine our characterization chronic bronchitics larger cohort analyze the CT correlates COPD subjects....

10.1186/1465-9921-15-52 article EN cc-by Respiratory Research 2014-04-27

Blood biomarkers are increasingly used to stratify high risk chronic obstructive pulmonary disease (COPD) patients; however, there fewer studies that have investigated multiple and replicated in large well-characterized cohorts of susceptible current former smokers. We two MSD multiplex panels measure 9 cytokines chemokines 2123 subjects from COPDGene 1117 SPIROMICS. These included: interleukin (IL)-2, IL-6, IL-8, IL-10, tumor necrosis factor (TNF)-α, interferon (IFN)-γ, eotaxin/CCL-11,...

10.1186/s12931-017-0662-2 article EN cc-by Respiratory Research 2017-10-24

BACKGROUND. Chronic obstructive pulmonary disease (COPD) is a heterogeneous smoking-related characterized by airway obstruction and inflammation. This inflammation may persist even after smoking cessation responds variably to corticosteroids. Personalizing treatment biologically similar "molecular phenotypes" improve therapeutic efficacy in COPD. IL-17A involved neutrophilic corticosteroid resistance, thus be particularly important COPD molecular phenotype.

10.1172/jci121087 article EN cc-by Journal of Clinical Investigation 2018-11-01

Chronic obstructive pulmonary disease (COPD) is variable in its development. Lung microbiota and metabolites collectively may impact COPD pathophysiology, but relationships to clinical outcomes milder are unclear.

10.1164/rccm.202110-2241oc article EN American Journal of Respiratory and Critical Care Medicine 2022-05-10

Post-acute sequelae of SARS-CoV-2 (PASC) is a poorly understood condition with significant impact on quality life. We aimed to better understand the lived experiences patients PASC, focusing cognitive complaints (“brain fog”) and fatigue (1) daily activities, (2) work/employment, (3) interpersonal relationships. conducted semi-structured qualitative interviews 15 Midwestern academic hospital’s post-COVID-19 clinic. audio-recorded, transcribed, analyzed thematically using combined...

10.3390/ijerph192315499 article EN International Journal of Environmental Research and Public Health 2022-11-23
Kristopher Opron Lesa Begley John R. Erb‐Downward Gen Li Neil E. Alexis and 88 more Igor Barjaktarević R. Graham Barr Eugene R. Bleecker Richard C. Boucher Russell P. Bowler Stephanie A. Christenson Alejandro P. Comellas Gerard J. Criner Christopher B. Cooper David Couper Craig J. Galbán MeiLan K. Han Annette T. Hastie Charles R. Hatt Eric A. Hoffman Robert J. Kaner Mehmet Kesımer Jerry A. Krishnan David C. LaFon Fernando J. Martínez Victor E. Ortega Stephen P. Peters Robert Paine Nirupama Putcha Prescott G. Woodruff Gary B. Huffnagle Ariangela J. Kozik Jeffrey L. Curtis Yvonne J. Huang Neil E. Alexis Wayne H. Anderson Mehrdad Arjomandi Igor Barjaktarević R. Graham Barr Patricia V. Basta Lori A. Bateman Christina Bellinger Surya P. Bhatt Eugene R. Bleecker Richard C. Boucher Russell P. Bowler Russell G. Buhr Stephanie A. Christenson Alejandro P. Comellas Christopher B. Cooper David Couper Gerard J. Criner Ronald G. Crystal Jeffrey L. Curtis Claire M. Doerschuk Mark T. Dransfield Michael Drummond Christine M. Freeman Craig J. Galbán Katherine Gershner MeiLan K. Han Nadia N. Hansel Annette T. Hastie Eric A. Hoffman Yvonne J. Huang Robert J. Kaner Richard E. Kanner Mehmet Kesımer Eric C. Kleerup Jerry A. Krishnan Wassim W. Labaki Lisa M. LaVange Stephen C. Lazarus Fernando J. Martínez Merry‐Lynn McDonald Deborah A. Meyers Wendy C. Moore John D. Newell Elizabeth C. Oelsner Jill Ohar Wanda K. O’Neal Victor E. Ortega Robert Paine Laura M. Paulin Stephen P. Peters Cheryl Pirozzi Nirupama Putcha Sanjeev Raman Stephen I. Rennard Donald P. Tashkin J. Michael Wells Robert A. Wise Prescott G. Woodruff

The airway microbiome has the potential to shape chronic obstructive pulmonary disease (COPD) pathogenesis, but its relationship outcomes in milder is unestablished.

10.1164/rccm.202303-0489oc article EN American Journal of Respiratory and Critical Care Medicine 2024-01-23

The impact of respiratory exacerbation on chronic obstructive pulmonary disease (COPD) is well established. effects exacerbations in people with cigarette smoking but normal spirometry are unknown. To assess the association lung function decline and mortality current or former history. We analyzed data from COPDGene participants ≥10 pack-years at enrollment (Visit 1) defined as post-bronchodilator forced expiratory volume 1 second (FEV1)/forced vital capacity (FVC) ≥lower limit (LLN) FEV1...

10.1164/rccm.202401-0023oc article EN American Journal of Respiratory and Critical Care Medicine 2025-02-13

Summary objective Serum cortisol levels rise in response to the stress of critical illness but optimal range serum such settings is not clearly defined. The objectives this study were determine a group medical intensive care unit patients with severe sepsis/septic shock using uniform criteria, and correlate mortality. design In prospective observational fashion, 100 at Northwestern Memorial Hospital Chicago enrolled within 48 h developing as defined by American College Chest...

10.1111/j.1365-2265.2004.01923.x article EN Clinical Endocrinology 2003-12-17

We set out to determine whether cellular hypoxia, via mitochondrial reactive oxygen species, promotes Na,K-ATPase degradation the ubiquitin-conjugating system. Cells exposed 1.5% O 2 had a decrease in activity and consumption. The total cell pool of α1 protein decreased on exposure for 30 hours, whereas plasma membrane was 50% degraded after hours which prevented by lysosome proteasome inhibitors. When Chinese hamster ovary cells that exhibit temperature-sensitive defect E1 ubiquitin...

10.1161/01.res.0000222418.99976.1d article EN Circulation Research 2006-04-14

Rationale: Previous studies on chronic bronchitis (CB) have used varying definitions.Objectives: We sought to compare an alternative CB definition, using the St. George's Respiratory Questionnaire (SGRQ), a commonly assessment tool, with classic definition and investigate if it had independent or additive value.Methods: analyzed data from 4,513 subjects Global Initiative for Chronic Obstructive Lung Disease groups 1 4 in COPDGene cohort. compared of SGRQ defined by their answers questions...

10.1513/annalsats.201411-518oc article EN Annals of the American Thoracic Society 2015-01-09
Coming Soon ...